Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Mengmeng Li, Biao Yu, Sicheng Wang, Fengjin Zhou, Jin Cui & Jiacan Su. (2023) Microenvironment-responsive nanocarriers for targeted bone disease therapy. Nano Today 50, pages 101838.
Crossref
Crossref
Hao Xu, Wentao Wang, Xin Liu, Wei Huang, Chen Zhu, Yaozeng Xu, Huilin Yang, Jiaxiang Bai & Dechun Geng. (2023) Targeting strategies for bone diseases: signaling pathways and clinical studies. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Jaqueline Aparecida Duarte, Eliza Rocha Gomes, André Luis Branco De Barros & Elaine Amaral Leite. (2023) Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines. Pharmaceutics 15:2, pages 369.
Crossref
Crossref
Arash Ramedani, Omid Sabzevari & Abdolreza Simchi. (2022) Hybrid ultrasound-activated nanoparticles based on graphene quantum dots for cancer treatment. International Journal of Pharmaceutics 629, pages 122373.
Crossref
Crossref
Gang Zheng, Hai-Wei Ma, Guang-Heng Xiang, Gao-Lu He, Han-Chen Cai, Zi-Han Dai, Yan-Lin Chen, Yan Lin, Hua-Zi Xu, Wen-Fei Ni, Cong Xu, Hai-Xiao Liu & Xiang-Yang Wang. (2022) Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Eliza Rocha Gomes, Fernanda Rezende Souza, Geovanni Dantas Cassali, Adriano de Paula Sabino, André Luis Branco de Barros & Mônica Cristina Oliveira. (2022) Investigation of the Antitumor Activity and Toxicity of Tumor-Derived Exosomes Fused with Long-Circulating and pH-Sensitive Liposomes Containing Doxorubicin. Pharmaceutics 14:11, pages 2256.
Crossref
Crossref
Beibei Hu, Yongkang Zhang, Guogang Zhang, Zhongqiu Li, Yongshuai Jing, Jun Yao & Shiguo Sun. (2022) Research progress of bone-targeted drug delivery system on metastatic bone tumors. Journal of Controlled Release 350, pages 377-388.
Crossref
Crossref
E. R. Gomes, A. T. Carvalho, T. C. Barbosa, L. L. Ferreira, H. D. R. Calado, A. P. Sabino & M. C. Oliveira. (2022) Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer. AAPS PharmSciTech 23:7.
Crossref
Crossref
Wucheng Wen, Pengbo Guo, Hui Yi Xue & Ho Lun Wong. (2022) Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasis. International Journal of Pharmaceutics 625, pages 122092.
Crossref
Crossref
Md. Abdur Rahman & Bungo Ochiai. (2022) A facile aqueous production of bisphosphonated-polyelectrolyte functionalized magnetite nanoparticles for pH-specific targeting of acidic-bone cells. RSC Advances 12:13, pages 8043-8058.
Crossref
Crossref
Nur Najihah Izzati Mat Rani, Xiang Yi Chen, Zahraa M. Al-Zubaidi, Hanisah Azhari, Tzar Mohd Nizam Khaitir, Pei Yuen Ng, Fhataheya Buang, Geok Chin Tan, Yin Ping Wong, Mazlina Mohd Said, Adeel Masood Butt, Azmy A. Hamid & Mohd Cairul Iqbal Mohd Amin. (2022) Surface-engineered liposomes for dual-drug delivery targeting strategy against methicillin-resistant Staphylococcus aureus (MRSA). Asian Journal of Pharmaceutical Sciences 17:1, pages 102-119.
Crossref
Crossref
Raquel Santos Faria, Luiza Ianny de Lima, Raphael Severino Bonadio, João Paulo Figueiró Longo, Marjorie Coimbra Roque, João Nunes de Matos Neto, Sergio Enrique Moya, Mônica Cristina de Oliveira & Ricardo Bentes Azevedo. (2021) Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer. Biomedicine & Pharmacotherapy 142, pages 112000.
Crossref
Crossref
M.V.M. Novais, E.R. Gomes, M.C. Miranda, J.O. Silva, D.A. Gomes, F.C. Braga, R.M. Pádua & M.C. Oliveira. (2021) Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines. Biomedicine & Pharmacotherapy 136, pages 111123.
Crossref
Crossref
Xin Gao, Lin Li, Xiaopan Cai, Quan Huang, Jianru Xiao & Yiyun Cheng. (2021) Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges. Biomaterials 265, pages 120404.
Crossref
Crossref
Marjan Abri Aghdam, Roya Bagheri, Jafar Mosafer, Behzad Baradaran, Mahmoud Hashemzaei, Amir Baghbanzadeh, Miguel de la Guardia & Ahad Mokhtarzadeh. (2019) Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release. Journal of Controlled Release 315, pages 1-22.
Crossref
Crossref
Juliana de Oliveira Silva, Renata Salgado Fernandes, Caroline Mari Ramos Oda, Tiago Hilário Ferreira, Ana Flávia Machado Botelho, Marília Martins Melo, Marcelo Coutinho de Miranda, Dawidson Assis Gomes, Geovanni Dantas Cassali, Danyelle M. Townsend, Domenico Rubello, Mônica Cristina Oliveira & André Luís Branco de Barros. (2019) Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model. Biomedicine & Pharmacotherapy 118, pages 109323.
Crossref
Crossref
Elham Hatami, Prashanth Kumar Bhusetty Nagesh, Pallabita Chowdhury, Stacie Elliot, Deanna Shields, Subhash Chand Chauhan, Meena Jaggi & Murali Mohan Yallapu. (2019) Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy. ACS Biomaterials Science & Engineering 5:5, pages 2343-2354.
Crossref
Crossref
M. Leonor Contreras, Camila Torres, Ignacio Villarroel & Roberto Rozas. (2018) Molecular dynamics assessment of doxorubicin–carbon nanotubes molecular interactions for the design of drug delivery systems. Structural Chemistry 30:1, pages 369-384.
Crossref
Crossref
Anna Corrêa, Mauricio Vericimo, Andriy Dashevskiy, Patricia Pereira & Vania Paschoalin. (2019) Liposomal Taro Lectin Nanocapsules Control Human Glioblastoma and Mammary Adenocarcinoma Cell Proliferation. Molecules 24:3, pages 471.
Crossref
Crossref
Yuqiong Xia, Mei Fang, Jingyu Dong, Chunzhong Xu, Zhen Liao, Pengbo Ning & Qi Zeng. (2018) pH sensitive liposomes delivering tariquidar and doxorubicin to overcome multidrug resistance of resistant ovarian cancer cells. Colloids and Surfaces B: Biointerfaces 170, pages 514-520.
Crossref
Crossref
Lauren D Field, Okhil K Nag, Ajmeeta Sangtani, Kelly E Burns & James B Delehanty. (2018) The role of nanoparticles in the improvement of systemic anticancer drug delivery. Therapeutic Delivery 9:7, pages 527-545.
Crossref
Crossref
Robert N Young & Marc D Grynpas. (2018) Targeting therapeutics to bone by conjugation with bisphosphonates. Current Opinion in Pharmacology 40, pages 87-94.
Crossref
Crossref
Pedro Lavrador, Vítor M. Gaspar & João F. Mano. (2018) Stimuli-responsive nanocarriers for delivery of bone therapeutics – Barriers and progresses. Journal of Controlled Release 273, pages 51-67.
Crossref
Crossref
Charlotte M Sevrain, Mathieu Berchel, Hélène Couthon & Paul-Alain Jaffrès. (2017) Phosphonic acid: preparation and applications. Beilstein Journal of Organic Chemistry 13, pages 2186-2213.
Crossref
Crossref
Yuchao Fan, Shengxiao Yuan, MengMeng Huo, Arka Sen Chaudhuri, Meihui Zhao, Zhenghong Wu & Xiaole Qi. (2017) Spatial controlled multistage nanocarriers through hybridization of dendrimers and gelatin nanoparticles for deep penetration and therapy into tumor tissue. Nanomedicine: Nanotechnology, Biology and Medicine 13:4, pages 1399-1410.
Crossref
Crossref
Patrick F. Forde & Katie B. Ryan. 2017. Orthopedic Biomaterials. Orthopedic Biomaterials
569
604
.